Thirteen months after Merck agreed to pay $100 million to settle litigation over the NuvaRing contraceptive, not a single active case remains in New Jersey.
March 04, 2015 at 01:59 PM
1 minute read
Thirteen months after Merck agreed to pay $100 million to settle litigation over the NuvaRing contraceptive, not a single active case remains in New Jersey.
Meanwhile, lawyers for the plaintiffs acknowledged that the settlement, which must be divided among thousands of claimants, is not as large as they had hoped but said it was as good as they could get, given the difficulty in proving liability.
Presented by BigVoodoo
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
